S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

BTAI BioXcel Therapeutics Inc

0.409

0.017 (4.34%)

04 Jan 2025 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

BioXcel Therapeutics (NASDAQ:BTAI)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more BioXcel Therapeutics Charts.

BioXcel Therapeutics (NASDAQ:BTAI)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more BioXcel Therapeutics Charts.

BioXcel Therapeutics Inc News

Form DEF 14A - Other definitive proxy statements
Tuesday 31 December 2024 (5 days ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Thursday 19 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 18 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 18 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 18 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 17 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 17 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 17 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 26 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Monday 25 November 2024 (1 month ago) • Edgar (US Regulatory)

BioXcel Therapeutics Announces Pricing of $7.0 Million Public Offering
Saturday 23 November 2024 (1 month ago) • GlobeNewswire Inc.

BioXcel Therapeutics Announces Proposed Public Offering
Friday 22 November 2024 (1 month ago) • GlobeNewswire Inc.

More BioXcel Therapeutics Inc News Articles

Gold vs US Dollar

Invesco QQQ Trust Series 1

Verizon Communications

Woodside Petroleum

Commonwealth Bank Of Aus...

Australia And New Zealan...

S&P ASX 300 Metals and M...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions